|
Volumn 42, Issue 3, 2008, Pages 215-217
|
Complete and durable remission in a patient with life-threatening scleromyxedema treated with high-dose melphalan and BU with auto-SCT
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMIN;
BETA 2 MICROGLOBULIN;
BUSULFAN;
COLCHICINE;
CYCLOPHOSPHAMIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IMMUNOGLOBULIN LAMBDA CHAIN;
IMMUNOGLOBULIN M;
MELPHALAN;
METHOTREXATE;
METHYLPREDNISOLONE;
MUCIN;
NARCOTIC ANALGESIC AGENT;
PENICILLAMINE;
PREDNISONE;
ADULT;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BONE MARROW BIOPSY;
CARPAL TUNNEL SYNDROME;
CASE REPORT;
CELL PROLIFERATION;
DIARRHEA;
DISEASE SEVERITY;
DRUG DOSE ESCALATION;
DRUG DOSE REGIMEN;
DRUG MEGADOSE;
DYSPHAGIA;
DYSPNEA;
ERECTILE DYSFUNCTION;
ERYTHEMA;
FATALITY;
FEBRILE NEUTROPENIA;
FIBROBLAST;
FLOW CYTOMETRY;
HUMAN;
HUMAN TISSUE;
HYPERPIGMENTATION;
INFECTION;
LETTER;
LUNG DIFFUSION CAPACITY;
MALE;
MUSCLE WEAKNESS;
NEUTROPHIL COUNT;
ORGAN TOXICITY;
PAPULE;
PARAPROTEINEMIA;
PERIPHERAL EDEMA;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
PROGNOSIS;
PRURITUS;
RAYNAUD PHENOMENON;
REMISSION;
SCLEROMYXEDEMA;
SKIN BIOPSY;
SKIN DEFECT;
STOMATITIS;
SYSTEMIC DISEASE;
THROMBOCYTE COUNT;
TREATMENT DURATION;
VOICE CHANGE;
BUSULFAN;
COMBINED MODALITY THERAPY;
HUMANS;
MALE;
MELPHALAN;
MIDDLE AGED;
SCLEROMYXEDEMA;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION, AUTOLOGOUS;
TREATMENT OUTCOME;
|
EID: 50049110257
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/bmt.2008.148 Document Type: Letter |
Times cited : (14)
|
References (8)
|